- Home
- KRYS vs SNDR Comparison
KRYS vs SNDR Comparison
Compare KRYS & SNDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRYS
- SNDR
- Stock Information
- Founded
- KRYS 2015
- SNDR 1935
- Country
- KRYS United States
- SNDR United States
- Employees
- KRYS N/A
- SNDR N/A
- Industry
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- SNDR Trucking Freight/Courier Services
- Sector
- KRYS Health Care
- SNDR Industrials
- Exchange
- KRYS Nasdaq
- SNDR Nasdaq
- Market Cap
- KRYS 4.5B
- SNDR 5.2B
- IPO Year
- KRYS 2017
- SNDR 2017
- Fundamental
- Price
- KRYS $148.39
- SNDR $29.75
- Analyst Decision
- KRYS Strong Buy
- SNDR Buy
- Analyst Count
- KRYS 7
- SNDR 14
- Target Price
- KRYS $206.67
- SNDR $29.08
- AVG Volume (30 Days)
- KRYS 292.3K
- SNDR 783.5K
- Earning Date
- KRYS 02-24-2025
- SNDR 01-30-2025
- Dividend Yield
- KRYS N/A
- SNDR 1.28%
- EPS Growth
- KRYS N/A
- SNDR N/A
- EPS
- KRYS 1.77
- SNDR 0.64
- Revenue
- KRYS $241,519,000.00
- SNDR $5,323,100,000.00
- Revenue This Year
- KRYS $485.65
- SNDR N/A
- Revenue Next Year
- KRYS $58.64
- SNDR $8.29
- P/E Ratio
- KRYS $83.69
- SNDR $46.71
- Revenue Growth
- KRYS 2722.80
- SNDR N/A
- 52 Week Low
- KRYS $107.50
- SNDR $20.50
- 52 Week High
- KRYS $219.34
- SNDR $33.90
- Technical
- Relative Strength Index (RSI)
- KRYS 37.81
- SNDR 48.99
- Support Level
- KRYS $141.72
- SNDR $28.06
- Resistance Level
- KRYS $152.94
- SNDR $30.80
- Average True Range (ATR)
- KRYS 5.22
- SNDR 0.64
- MACD
- KRYS -0.42
- SNDR 0.14
- Stochastic Oscillator
- KRYS 33.00
- SNDR 61.68
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About SNDR Schneider National Inc.
Schneider National Inc is a provider of surface transportation and logistics solutions in North America. The Company offers truckload, intermodal, and logistics services to a diverse customer base throughout the continental United States, Canada, and Mexico. The company's segments include Truckload; Intermodal; Logistics and other. It generates maximum revenue from the Truckload segment.